Vipul Jairath

122PUBLICATIONS
179CO-AUTHORS
Predictive and prognostic markersMajor global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (122)

|Aug 08, 2026
Comparative risk of postoperative complications in ulcerative colitis patients following preoperative advanced therapies: a network meta-analysis with meta-regression.

|Jul 23, 2026
Classifications of rheumatological extraintestinal manifestations in inflammatory bowel disease: Unmet needs in clinical practice and trials.

|Jul 03, 2026
Patients with Crohn's disease achieving transmural healing experience superior long-term outcomes compared with those with endoscopic or radiologic healing alone.

|Jun 30, 2026
Prior exposure to advanced therapy and timing of discontinuation and risk of serious infections in patients with inflammatory bowel disease initiating a new advanced therapy.

|Jun 26, 2026
The impact of global recruitment and country income on placebo rates in inflammatory bowel disease clinical trials.

|Jun 17, 2026
Histologic and combined histologic-endoscopic outcomes with mirikizumab in Crohn's disease: VIVID-1 trial results.

Pageof 21

Frequent Collaborators

34 joint publications

Christopher Ma

20 joint publications

Brian G Feagan

17 joint publications

Siddharth Singh

16 joint publications

Silvio Danese